Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy may slightly increase sexual desire in women with HSDD but lacks broad recommendation due to safety concerns and limited approval.

Finasteride may cause long-lasting sexual side effects.

Finasteride for hair loss increases risk of long-lasting sexual dysfunction.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Finasteride helps reduce priapism in sickle cell anemia patients.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Hair loss drugs like finasteride may cause lasting sexual and mood side effects, and more research is needed to understand these risks.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Over-the-counter products can help with menopause symptoms, but be aware of their ingredients.

Testosterone may help increase sexual events for women with low libido due to antidepressants.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

About 15% of US Army personnel use hair products containing hormone or placenta, with higher usage among non-whites, females, and enlisted personnel.

Participating in Sexual Orientation Change Efforts may increase the risk of suicide for sexual minority individuals.

Finasteride may cause lasting sexual, mental, and physical symptoms; use with caution.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Public awareness of finasteride's sexual side effects has increased, suggesting healthcare providers should discuss these risks more thoroughly with patients.

The document sets criteria for diagnosing long-term sexual dysfunctions caused by certain medications.

Natesto nasal gel improves erectile function and mood in men with low testosterone within 30 days.

Finasteride may cause lasting sexual issues by altering specific genes in human cells.

Short-acting testosterone injections in a clinic are a preferred treatment for low testosterone because they work well, are convenient, and patients stick with the treatment.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Man experienced lasting sexual dysfunction from finasteride, but malpractice claim was rejected.

Long-term testosterone treatment helps men with low testosterone levels lose weight.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.